IM Cannabis (IMCC) Notes Payables (2021 - 2025)

IM Cannabis' Notes Payables history runs 5 years deep, the most recent figure standing at $10.3 million for Q4 2025.

• On a quarterly basis, Notes Payables fell 5.2% year-over-year to $10.3 million in Q4 2025; TTM through Dec 2025 was $10.3 million, a 5.2% decrease from a year earlier, with the FY2025 full-year figure at $10.3 million, down 7.09% from the prior year.
• Notes Payables climbed to $10.3 million in Q4 2025 per IMCC's latest filing, from -$413968.4 in the prior quarter.
• Across five years, Notes Payables topped out at $14.1 million in Q2 2022 and bottomed at -$413968.4 in Q1 2025.
• The 5-year median for Notes Payables is $8.9 million (2024), against an average of $8.2 million.
• Across the five-year window, Notes Payables soared 91.9% in 2023 and tumbled 104.67% in 2025, its largest moves.
• Year by year, Notes Payables stood at $6.9 million in 2021, then fell by 1.13% to $6.8 million in 2022, then surged by 30.69% to $8.9 million in 2023, then advanced by 21.79% to $10.8 million in 2024, then declined by 5.2% to $10.3 million in 2025.
• Per Business Quant, the three latest IMCC Notes Payables figures stand at $10.3 million (Q4 2025), -$413968.4 (Q1 2025), and $10.8 million (Q4 2024).